Related references
Note: Only part of the references are listed.Protective effect and antibody response of DNA vaccine against salmonid alphavirus 3 (SAV3) in Atlantic salmon
C. J. Chang et al.
JOURNAL OF FISH DISEASES (2017)
HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV
Vijaya Madhavi et al.
JOURNAL OF VIROLOGY (2017)
Targeted Immune Interventions for an HIV-1 Cure
Matthieu Perreau et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
S. Stenler et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Fusion to Flaviviral Leader Peptide Targets HIV-1 Reverse Transcriptase for Secretion and Reduces Its Enzymatic Activity and Ability to Induce Oxidative Stress but Has No Major Effects on Its Immunogenic Performance in DNA-Immunized Mice
Anastasia Latanova et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
Susan P. Buchbinder et al.
PLOS ONE (2017)
Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer
V. P. Baklaushev et al.
SCIENTIFIC REPORTS (2017)
Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial
G. Haidari et al.
SCIENTIFIC REPORTS (2017)
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
J. Hinkula et al.
HELIYON (2017)
Dying cells actively regulate adaptive immune responses
Nader Yatim et al.
NATURE REVIEWS IMMUNOLOGY (2017)
DNA Vaccine Delivery and Improved Immunogenicity
Kevin R. Porter et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2017)
Clinical potential of electroporation for gene therapy and DNA vaccine delivery
Laure Lambricht et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Lei Li et al.
EXPERT REVIEW OF VACCINES (2016)
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics
Serena Brundu et al.
JOURNAL OF VIROLOGY (2016)
Control of HIV-1 replication in vitro by vaccine-induced human CDS+ T cells through conserved subdominant Pol epitopes
Tina Ahmed et al.
VACCINE (2016)
A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy
Frank Y. Tung et al.
VACCINE (2016)
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
S. H. T. Jorritsma et al.
VACCINE (2016)
DNA immunization as a technology platform for monoclonal antibody induction
Shuying Liu et al.
EMERGING MICROBES & INFECTIONS (2016)
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R. Fouts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials
Xia Jin et al.
VACCINE (2015)
Recent insights into cutaneous immunization: How to vaccinate via the skin
Laura Engelke et al.
VACCINE (2015)
Multifarious immunotherapeutic approaches to cure HIV-1 infection
Nesrina Imami et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?
Henrique Lemos et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
Patricia. J. Munseri et al.
PLoS One (2015)
HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
Charlotta Nilsson et al.
PLOS ONE (2015)
Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults
Agricola Joachim et al.
PLOS ONE (2015)
Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
Thomas Grunwald et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Stimulation of Innate Immunity by In Vivo Cyclic di-GMP Synthesis Using Adenovirus
Benjamin J. Koestler et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Improving DNA Vaccine Performance Through Vector Design
James A. Williams
CURRENT GENE THERAPY (2014)
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load
Yves Levy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Colocalization of Cell Death with Antigen Deposition in Skin Enhances Vaccine Immunogenicity
Alexandra C. I. Depelsenaire et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
c-di-GMP Enhances Protective Innate Immunity in a Murine Model of Pertussis
Shokrollah Elahi et al.
PLOS ONE (2014)
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
A. Saez-Cirion et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag
Tamsin J. Garrod et al.
VIRUS RESEARCH (2014)
Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages
Meera Rath et al.
FRONTIERS IN IMMUNOLOGY (2014)
DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
Barney S. Graham et al.
PLOS ONE (2013)
Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+and CD8+T Cells
Olga Krotova et al.
PLOS ONE (2013)
Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging
Stefan P. Petkov et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization
Maria Isaguliants et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities
Peter M. Gray et al.
CELLULAR IMMUNOLOGY (2012)
Technologies for enhanced efficacy of DNA vaccines
Fadi Saade et al.
EXPERT REVIEW OF VACCINES (2012)
Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine
Maria L. Knudsen et al.
JOURNAL OF VIROLOGY (2012)
The Biased Nucleotide Composition of HIV-1 Triggers Type I Interferon Response and Correlates with Subtype D Increased Pathogenicity
Nicolas Vabret et al.
PLOS ONE (2012)
Can immunotherapy be useful as a functional cure for infection with Human Immunodeficiency Virus-1?
Guido Vanham et al.
RETROVIROLOGY (2012)
Optimization of Electroporation-Enhanced Intradermal Delivery of DNA Vaccine Using a Minimally Invasive Surface Device
Feng Lin et al.
HUMAN GENE THERAPY METHODS (2012)
Cellular Immunogenicity of Novel Gene Immunogens in Mice Monitored by In Vivo Imaging
Elizaveta Starodubova et al.
MOLECULAR IMAGING (2012)
Aging and Immune Function: Molecular Mechanisms to Interventions
Subramaniam Ponnappan et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Intradermal naked plasmid DNA immunization: mechanisms of action
Mazal Elnekave et al.
EXPERT REVIEW OF VACCINES (2011)
HIV-1 adaptation to NK-cell-mediated immune pressure
Galit Alter et al.
NATURE (2011)
Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity
David Hallengard et al.
VACCINE (2011)
Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection
Gamze Isitman et al.
VIROLOGY (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Strong HIV-Specific CD4+ and CD8+ T-Lymphocyte Proliferative Responses in Healthy Individuals Immunized with an HIV-1 DNA Vaccine and Boosted with Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 Genes
Said Aboud et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Per-Channel Basis Normalization Methods for Flow Cytometry Data
Florian Hahne et al.
CYTOMETRY PART A (2010)
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
Evelien M. Bunnik et al.
NATURE MEDICINE (2010)
Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization
Elizaveta Starodubova et al.
VACCINE (2010)
The potential of 3′,5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant
Wangxue Chen et al.
VACCINE (2010)
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
Greg L. Beilhartz et al.
VIRUSES-BASEL (2010)
flowCore: a Bioconductor package for high throughput flow cytometry
Florian Hahne et al.
BMC BIOINFORMATICS (2009)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
Sarah M. McWhirter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy
Carlum Shiu et al.
JOURNAL OF VIROLOGY (2009)
Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients
Anna-Karin Roos et al.
MOLECULAR THERAPY (2009)
Adaptation of HIV-1 to human leukocyte antigen class I
Yuka Kawashima et al.
NATURE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Vaccination against drug resistance in HIV infection
Andreas Boberg et al.
EXPERT REVIEW OF VACCINES (2008)
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
Godwin Nchinda et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes
Carina L. Perez et al.
JOURNAL OF IMMUNOLOGY (2008)
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo Electroporation
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2008)
HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective
Jonathan M. Carlson et al.
MICROBES AND INFECTION (2008)
Structure-based antigen design: a strategy for next generation vaccines
Philip R. Dormitzer et al.
TRENDS IN BIOTECHNOLOGY (2008)
HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response
Elizaveta S. Starodubova et al.
VACCINE (2008)
C-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection
Abiodun D. Ogunniyi et al.
VACCINE (2008)
Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins
AV Ivanov et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization
A Boberg et al.
VACCINE (2006)
HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1
Elizaveta Starodubova et al.
VACCINE (2006)
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
Shixia Wang et al.
VACCINE (2006)
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine
Lucy Dorrell et al.
JOURNAL OF VIROLOGY (2006)
Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery
A Bråve et al.
MOLECULAR THERAPY (2005)
The rationale behind a vaccine based on multiple HIV antigens
E Rollman et al.
MICROBES AND INFECTION (2005)
Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding Mycobacterial antigen Ag85B
HJ Ko et al.
INFECTION AND IMMUNITY (2005)
DNA vaccines: Progress and challenges
JJ Donnelly et al.
JOURNAL OF IMMUNOLOGY (2005)
Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGY (2005)
Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model
MG Isaguliants et al.
VACCINE (2004)
Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA
AK Zuber et al.
VACCINE (2004)
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene
L Frelin et al.
GENE THERAPY (2004)
Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase
MG Isaguliants et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Codon optimization of the Tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization
L Ramakrishna et al.
JOURNAL OF VIROLOGY (2004)
Heme oxygenase-1 modulates early inflammatory responses - Evidence from the heme oxygenase-1-deficient mouse
MH Kapturczak et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Plasmid encoding papillomavirus type 16 (HPV 16) DNA constructed with codon optimization improved the immunogenicity against HPV infection
YK Cheung et al.
VACCINE (2004)
Multiprotein HIV type 1 clade B DNA/MVA vaccine: Construction, safety, and immunogenicity in macaques
JM Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Effect of electric field vectoriality on electrically mediated gene delivery in mammalian cells
C Faurie et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle
KR Young et al.
VIROLOGY (2004)
Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo
J Hinkula et al.
CELLS TISSUES ORGANS (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Cell and animal imaging of electrically mediated gene transfer
C Faurie et al.
DNA AND CELL BIOLOGY (2003)
DNA vaccine strategies: candidates for immune modulation and immunization regimens
NA Doria-Rose et al.
METHODS (2003)
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA Vaccines
JZ Megede et al.
JOURNAL OF VIROLOGY (2003)
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA Vaccines
WP Kong et al.
JOURNAL OF VIROLOGY (2003)
Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice
DL Narum et al.
INFECTION AND IMMUNITY (2001)
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein
L Deml et al.
JOURNAL OF VIROLOGY (2001)
Antigen presentation and DNA vaccines
JJ Donnelly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1-specific immune responses
K Luzuriaga et al.
JOURNAL OF VIROLOGY (2000)
Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits
MG Isaguliants et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
Share Paper
